Parkinson’s Disease and glucose dysregulation: shared pathophysiological mechanisms and clinical implications
Investigation of the common pathophysiological mechanisms of PD and T2DM may lead to new treatment strategies for both diseases. Ongoing studies of the efficacy and safety of antidiabetic drugs in PD, particularly in larger populations, are essential to validate their long-term benefits and therapeutic potential.
Authors
- Zbigniew K. Wszołek (ORCID: https://orcid.org/0000-0001-5487-1053)
- Jessica R. Wilson (ORCID: https://orcid.org/0000-0003-0402-5830)
- Tomasz Chmiela (ORCID: https://orcid.org/0000-0001-6022-7731)
Institutions
- Medical University of Silesia (PL)
- Jacksonville College (US)
- WinnMed (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- Neurologia i Neurochirurgia Polska
- Published
- 2025-05-19
- DOI
- https://doi.org/10.5603/pjnns.104405
- Citations
- 2
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.78